Literature DB >> 25930135

Abuse and diversion of gabapentin among nonmedical prescription opioid users in Appalachian Kentucky.

Rachel V Smith1, Michelle R Lofwall, Jennifer R Havens.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25930135      PMCID： PMC4864031          DOI： 10.1176/appi.ajp.2014.14101272

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  8 in total

1.  Effect of abuse-deterrent formulation of OxyContin.

Authors:  Theodore J Cicero; Matthew S Ellis; Hilary L Surratt
Journal:  N Engl J Med       Date:  2012-07-12       Impact factor: 91.245

Review 2.  Misuse and abuse of pregabalin and gabapentin: cause for concern?

Authors:  Fabrizio Schifano
Journal:  CNS Drugs       Date:  2014-06       Impact factor: 5.749

3.  Potentiation of the effect of buprenorphine/naloxone with gabapentin or quetiapine.

Authors:  Roy R Reeves; Mark E Ladner
Journal:  Am J Psychiatry       Date:  2014-06       Impact factor: 18.112

4.  Gabapentin abuse, and delirium tremens upon gabapentin withdrawal.

Authors:  Christopher Pittenger; Paul H Desan
Journal:  J Clin Psychiatry       Date:  2007-03       Impact factor: 4.384

Review 5.  Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery.

Authors:  Charles P Taylor; Timothy Angelotti; Eric Fauman
Journal:  Epilepsy Res       Date:  2006-11-28       Impact factor: 3.045

6.  Individual and network factors associated with prevalent hepatitis C infection among rural Appalachian injection drug users.

Authors:  Jennifer R Havens; Michelle R Lofwall; Simon D W Frost; Carrie B Oser; Carl G Leukefeld; Richard A Crosby
Journal:  Am J Public Health       Date:  2012-11-15       Impact factor: 9.308

7.  Gabapentinoid abuse in order to potentiate the effect of methadone: a survey among substance misusers.

Authors:  Colin R W Baird; Pauline Fox; Lesley A Colvin
Journal:  Eur Addict Res       Date:  2013-10-31       Impact factor: 3.015

8.  The impact of a reformulation of extended-release oxycodone designed to deter abuse in a sample of prescription opioid abusers.

Authors:  Jennifer R Havens; Carl G Leukefeld; Angela M DeVeaugh-Geiss; Paul Coplan; Howard D Chilcoat
Journal:  Drug Alcohol Depend       Date:  2014-02-26       Impact factor: 4.492
  8 in total
  33 in total

Review 1.  Abuse and Misuse of Pregabalin and Gabapentin.

Authors:  Kirk E Evoy; Megan D Morrison; Stephen R Saklad
Journal:  Drugs       Date:  2017-03       Impact factor: 9.546

Review 2.  Pharmacologic Treatment of Opioid Use Disorder: a Review of Pharmacotherapy, Adjuncts, and Toxicity.

Authors:  Michael S Toce; Peter R Chai; Michele M Burns; Edward W Boyer
Journal:  J Med Toxicol       Date:  2018-10-30

3.  The Toxicology Investigators Consortium Case Registry-the 2017 Annual Report.

Authors:  Lynn A Farrugia; Sean H Rhyee; Sharan L Campleman; Bryan Judge; Louise Kao; Anthony Pizon; Lauren Porter; Anne M Riederer; Timothy Wiegand; Diane Calello; Paul M Wax; Jeffrey Brent
Journal:  J Med Toxicol       Date:  2018-08-09

4.  Gabapentin prescribed during substance abuse treatment: The perspective of treatment providers.

Authors:  Mance E Buttram; Steven P Kurtz; Matthew S Ellis; Theodore J Cicero
Journal:  J Subst Abuse Treat       Date:  2019-07-21

5.  Oxycodone-induced tolerance to respiratory depression: reversal by ethanol, pregabalin and protein kinase C inhibition.

Authors:  Rob Hill; William L Dewey; Eamonn Kelly; Graeme Henderson
Journal:  Br J Pharmacol       Date:  2018-05-07       Impact factor: 8.739

6.  Trends in unintentional polysubstance overdose deaths and individual and community correlates of polysubstance overdose, North Carolina, 2009-2018.

Authors:  Mary C Figgatt; Anna E Austin; Mary E Cox; Scott Proescholdbell; Stephen W Marshall; Rebecca B Naumann
Journal:  Drug Alcohol Depend       Date:  2021-01-02       Impact factor: 4.492

7.  A qualitative analysis of gabapentin misuse and diversion among people who use drugs in Appalachian Kentucky.

Authors:  Rachel Vickers Smith; Elaine M Boland; April M Young; Michelle R Lofwall; Alexa Quiroz; Michele Staton; Jennifer R Havens
Journal:  Psychol Addict Behav       Date:  2017-12-14

8.  Opioid-related overdose deaths among African Americans: Implications for research, practice and policy.

Authors:  Danelle Stevens-Watkins
Journal:  Drug Alcohol Rev       Date:  2020-04-12

9.  An ethnographic decision model of the initiation of gabapentin misuse among prescription and/or illicit opioid (mis)user.

Authors:  Mance E Buttram; Steven P Kurtz; Theodore J Cicero; Jennifer R Havens
Journal:  Drug Alcohol Depend       Date:  2019-09-13       Impact factor: 4.492

10.  Factors Associated with Gabapentin Misuse among People Who Inject Drugs in Appalachian Kentucky.

Authors:  Mance E Buttram; Hilary L Surratt
Journal:  Subst Use Misuse       Date:  2020-09-11       Impact factor: 2.164
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.